Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis

PT Yeh, CE Kennedy, H De Vuyst, M Narasimhan - BMJ global health, 2019 - gh.bmj.com
Introduction Human papillomavirus (HPV) self-sampling test kits may increase screening for
and early detection of cervical cancer and reduce its burden globally. To inform WHO self …

Cervical cancer screening postpandemic: self-sampling opportunities to accelerate the elimination of cervical cancer

T Lozar, R Nagvekar, C Rohrer… - … Journal of Women's …, 2021 - Taylor & Francis
The persisting burden of cervical cancer in underserved populations and low-resource
regions worldwide, worsened by the onset of the COVID-19 pandemic, requires proactive …

Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening

S Costa, B Verberckmoes, PE Castle… - British Journal of Cancer, 2023 - nature.com
Background Human papillomavirus (HPV) testing on self-samples represents a great
opportunity to increase cervical cancer screening uptake among under-screened women …

Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies …

G Di Gennaro, F Licata, A Trovato… - Frontiers in public health, 2022 - frontiersin.org
Objectives A meta-analysis was conducted to examine the effectiveness of HPV self-
sampling proposal on cervical cancer screening (CCS) uptake when compared with an …

Widening the offer of human papillomavirus self‐sampling to all women eligible for cervical screening: make haste slowly

M Rebolj, A Sargent, SH Njor… - International journal of …, 2023 - Wiley Online Library
Self‐collection of samples for human papillomavirus (HPV) testing has the potential to
increase the uptake of cervical screening among underscreened women and will likely form …

Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial

M Fujita, K Nagashima, M Shimazu, M Suzuki, I Tauchi… - Plos one, 2023 - journals.plos.org
Purpose In terms of medical policy for cervical cancer prevention, Japan lags far behind
other industrialized countries. We initiated a randomized controlled trial to evaluate the self …

Implementation of a self-sampling HPV test for non-responders to cervical cancer screening in Japan: secondary analysis of the ACCESS trial

M Fujita, K Nagashima, M Shimazu, M Suzuki… - Scientific Reports, 2022 - nature.com
A self-sampling human papillomavirus (HPV) test could improve the morbidity and mortality
of cervical cancer in Japan. However, its effectiveness and feasibility have not been …

Quality assured implementation of the Slovenian breast cancer screening programme

K Jarm, M Kadivec, C Šval, K Hertl, M Primic Žakelj… - PloS one, 2021 - journals.plos.org
Setting The organised, population-based breast cancer screening programme in Slovenia
began providing biennial mammography screening for women aged 50–69 in 2008. The …

Effectiveness of self‐sampling human papillomavirus test on precancer detection and screening uptake in Japan: The ACCESS randomized controlled trial

M Fujita, K Nagashima, M Shimazu… - … Journal of Cancer, 2024 - Wiley Online Library
Japan is lagging in cervical cancer prevention. The effectiveness of a self‐sampling human
papillomavirus (HPV) test, a possible measure to overcome this situation, has not yet been …

[HTML][HTML] Methodological errors in clinical studies published by medical journals of ex-Yugoslav countries

SM Jankovic, I Masic - Acta Informatica Medica, 2020 - ncbi.nlm.nih.gov
Aim: The aim of this study was to compare the methodological quality of clinical trials and
observational studies published in medical journals from ex-Yugoslav countries indexed in …